banner
HCV protease inhibitor Paritaprevir, Purity ≥98%

Cat. No.: X24-07-ZQ108

HCV protease inhibitor Paritaprevir, Purity ≥98%

Synonym: 1216941-48-8; HCV protease inhibitor; ATB450; ABT-450; ABT 450; Paritaprevir; Veruprevir; Brand name: VIEKIRA PAK

  • CAS Number: 1216941-48-8
  • Compound CID: 45110509
Product Size
5 mg; 10 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
Paritaprevir, soluble in DMSO, targets and inhibits the function of the hepatitis C virus protease enzyme.
Molecular Weight
765.88
Molecular Formula
C40H43N7O7S
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 97 mg/mL (126.64 mM)
Identity
Confirmed by NMR/HPLC/MS.
Applications
Paritaprevir is investigated for its inhibitory effects on the NS3/4A protease, essential for HCV replication, making it a candidate for hepatitis C treatment.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0